Affiliation:
1. Center for Drug Delivery Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA
2. College of Pharmacy, Larkin University, 18301 N Miami Ave, Miami, FL 33169, USA
Abstract
The molecule (S)-4,5-dihydroxy-2,3-pentanedione (DPD) is produced by many different species of bacteria and is involved in bacterial communication. DPD is the precursor of signal molecule autoinducer-2 (AI-2) and has high potential to be used as a vaccine adjuvant. Vaccine adjuvants are compounds that enhance the stability and immunogenicity of vaccine antigens, modulate efficacy, and increase the immune response to a particular antigen. Previously, the microparticulate form of (S)-DPD was found to have an adjuvant effect with the gonorrhea vaccine. In this study, we evaluated the immunogenicity and adjuvanticity of several synthetic analogs of the (S)-DPD molecule, including ent—DPD((R)-4,5-dihydroxy-2,3-pentanedione), n-butyl—DPD ((S)-1,2-dihydroxy-3,4-octanedione), isobutyl—DPD ((S)-1,2-dihydroxy-6-methyl-3,4-heptanedione), n-hexyl—DPD ((S)-1,2-dihydroxy-3,4-decanedione), and phenyl—DPD ((S)-3,4-dihydroxy-1-phenyl-1,2-butanedione), in microparticulate formulations. The microparticulate formulations of all analogs of (S)-DPD were found to be noncytotoxic toward dendritic cells. Among these analogs, ent—DPD, n-butyl—DPD, and isobutyl—DPD were found to be immunogenic toward antigens and showed adjuvant efficacy with microparticulate gonorrhea vaccines. It was observed that n-hexyl—DPD and phenyl—DPD did not show any adjuvant effect. This study shows that synthetic analogs of (S)-DPD molecules are capable of eliciting adjuvant effects with vaccines. A future in vivo evaluation will further confirm that these analogs are promising vaccine adjuvants.
Funder
College of Pharmacy Internal Grant
Mercer University Seed Grant
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference50 articles.
1. Vaccine adjuvants revisited;Aguilar;Vaccine,2007
2. Baba, T.A.M., and Akashi, M. (2011). Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems, Springer.
3. Recent advances in vaccine adjuvants;Singh;Pharm. Res.,2002
4. Aluminum compounds as vaccine adjuvants;Gupta;Adv. Drug Deliv. Rev.,1998
5. Advances in saponin-based adjuvants;Sun;Vaccine,2009